TCTR20191022003尚未招募3 期
Apixaban for the prevention of venous thromboembolism in patients with spine metastasis, a randomized placebo-controlled trial
Faculty of Medicine, Chiang Mai university0 个研究点目标入组 120 人开始时间: 2019年10月22日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •Inclusion criteria
- •Subjects must meet all of the inclusion criteria to participate in this study.
- •1. Age ≥ 18 years
- •2. Any cancer with spine metastasis
- •3. Life expectancy ≥ 6 months
- •4. Provide written informed consent
排除标准
- •Exclusion criteria
- •Subjects meeting any of the exclusion criteria at baseline screening will be excluded from study participation.
- •1. History of major bleeding that in judgment of the investigator precludes use of anticoagulant prophylaxis
- •2. History of significant hepatic diseases or any condition that in the judgement of the investigator precludes the use of apixaban
- •3. Creatinine clearance less than 30 ml/min (calculated by Cockcroft-Gault formula)
- •4. Platelet count less than 75 x 109 /L
- •5. Need for long-term anticoagulation due to preexisting co-morbid condition or due to the development of VTE following surgery but prior to randomization
- •6. Chronic daily aspirin use with dose greater than 100 mg per day
- •7. Known allergies to ingredients contained in apixaban
- •8. Pregnancy or lactation
研究者
相似试验
尚未招募
3 期
A Trial To assess role of thromboprophylaxis by Apixaban in Advanced Epithelial Ovarian Cancer patients receiving Neoadjuvant ChemotherapyCTRI/2024/06/068730All India Institute of Medical Sciences
进行中（未招募）
1 期
Apixaban for the treatment of venous thromboembolism in patients with cancerVenous thromboembolism in cancer patientsMedDRA version: 21.1Level: LLTClassification code 10066899Term: Venous thromboembolismSystem Organ Class: 100000004866EUCTR2016-003093-40-ITFONDAZIONE FADOI1,168
进行中（未招募）
1 期
Apixaban for the treatment of venous thromboembolism in patients with cancerVenous thromboembolism in cancer patientsEUCTR2016-003093-40-NLFONDAZIONE FADOI70
进行中（未招募）
1 期
Apixaban for the treatment of venous thromboembolism in patients with cancerEUCTR2016-003093-40-DEFondazione FADOI1,200
已完成
3 期
Apixaban for the treatment of venous thromboembolism in patients with cancer: a prospective randomized open blinded end-point (probe) study - the Caravaggio studyNL-OMON50094Fondazione FADOI Italian Federation of Hospital Internists180